<DOC>
	<DOCNO>NCT00211588</DOCNO>
	<brief_summary>The aim study determine whether galantamine stabilize improve think ability individual Parkinson 's disease . Individuals include study minor complaint think problem concentration memory dementia . This medication show positive effect stabilize memory individual Alzheimer 's disease . It FDA approve use elderly individual Alzheimer 's disease . It hypothesize galantamine stabilize improve executive attentional function individual Parkinson 's .</brief_summary>
	<brief_title>Galantamine Executive Function Parkinson 's Disease</brief_title>
	<detailed_description>While several cholinesterase inhibitor effectiveness Alzheimer 's disease ( AD ) , galantamine unique since dual mode action : inhibition acetylcholinesterase modulation nicotinic acetylcholine receptors.As Parkinson 's disease ( PD ) impact frontal system , executive cognition rather memory function ( mediate medial temporal ) would target area potential improvement . This single center , double blind , placebo control study compare group PD patient treat galantamine group PD patient treat medication series cognitive task examine attention executive control .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Galantamine</mesh_term>
	<criteria>Idiopathic Parkinson 's Disease dementia , depression , cardiac disease , gastrointestinal disease</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>cognition</keyword>
</DOC>